These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 34618858)

  • 1. Risk factors for microbiologic failure in children with Enterobacter species bacteremia.
    Boguniewicz J; Revell PA; Scheurer ME; Hulten KG; Palazzi DL
    PLoS One; 2021; 16(10):e0258114. PubMed ID: 34618858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enterobacter bacteremia: Clinical features, risk factors for multiresistance and mortality in a Chinese University Hospital.
    Ye Y; Li JB; Ye DQ; Jiang ZJ
    Infection; 2006 Oct; 34(5):252-7. PubMed ID: 17033748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors associated to prevalence and treatment of carbapenem-resistant Enterobacteriaceae infections: a seven years retrospective study in three tertiary care hospitals.
    Pang F; Jia XQ; Zhao QG; Zhang Y
    Ann Clin Microbiol Antimicrob; 2018 Mar; 17(1):13. PubMed ID: 29571291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carbapenem-resistant
    Ruvinsky S; Voto C; Roel M; Deschutter V; Ferraro D; Aquino N; Reijtman V; Galvan ME; Motto E; García M; Sarkis C; Bologna R
    Front Public Health; 2022; 10():983174. PubMed ID: 36091556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors and outcome of extended-spectrum β-lactamase-producing Enterobacter cloacae bloodstream infections.
    Qureshi ZA; Paterson DL; Pakstis DL; Adams-Haduch JM; Sandkovsky G; Sordillo E; Polsky B; Peleg AY; Bhussar MK; Doi Y
    Int J Antimicrob Agents; 2011 Jan; 37(1):26-32. PubMed ID: 21075605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive value of prior colonization and antibiotic use for third-generation cephalosporin-resistant enterobacteriaceae bacteremia in patients with sepsis.
    Rottier WC; Bamberg YR; Dorigo-Zetsma JW; van der Linden PD; Ammerlaan HS; Bonten MJ
    Clin Infect Dis; 2015 Jun; 60(11):1622-30. PubMed ID: 25694654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increasing Enterobacter bacteremia in pediatric patients.
    Andresen J; Asmar BI; Dajani AS
    Pediatr Infect Dis J; 1994 Sep; 13(9):787-92. PubMed ID: 7808847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enterobacteriaceae Sepsis Outcome Programme annual report, 2013.
    Turnidge JD; Gottlieb T; Mitchell DH; Coombs GW; Daly DA; Bell JM;
    Commun Dis Intell Q Rep; 2014 Dec; 38(4):E327-33. PubMed ID: 25631595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends in antimicrobial resistance and empiric antibiotic therapy of bloodstream infections at a general hospital in Mid-Norway: a prospective observational study.
    Mehl A; Åsvold BO; Kümmel A; Lydersen S; Paulsen J; Haugan I; Solligård E; Damås JK; Harthug S; Edna TH
    BMC Infect Dis; 2017 Feb; 17(1):116. PubMed ID: 28148226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibiotic resistance in adult female patients hospitalized for acute pyelonephritis: rates and predicting factors.
    Etienne M; Van Elslande H; Choplin-Renard J; Pestel-Caron M; Caron F
    Med Mal Infect; 2014 May; 44(5):217-22. PubMed ID: 24787633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a bedside tool to predict the probability of drug-resistant pathogens among hospitalized adult patients with gram-negative infections.
    Lodise TP; Bonine NG; Ye JM; Folse HJ; Gillard P
    BMC Infect Dis; 2019 Aug; 19(1):718. PubMed ID: 31412809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment outcomes in patients with third-generation cephalosporin-resistant Enterobacter bacteremia.
    O'Neal CS; O'Neal HR; Daniels TL; Talbot TR
    Scand J Infect Dis; 2012 Oct; 44(10):726-32. PubMed ID: 22681412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Clinical Evaluation of Third-generation Cephalosporins As Definitive Therapy for Enterobacter spp. and Klebsiella aerogenes Bacteremia.
    Kobayashi K; Hata A; Imoto W; Kakuno S; Shibata W; Yamada K; Kawaguchi H; Sakurai N; Nakaie K; Nakatsuka Y; Ito T; Uenoyama K; Takahashi T; Ueda S; Katayama T; Onoue M; Kakeya H
    Intern Med; 2023 Jul; 62(13):1921-1929. PubMed ID: 36384899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment options and clinical outcomes for carbapenem-resistant Enterobacteriaceae bloodstream infection in a Chinese university hospital.
    Li C; Li Y; Zhao Z; Liu Q; Li B
    J Infect Public Health; 2019; 12(1):26-31. PubMed ID: 30145151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enterobacter bacteremia. An analysis of 50 episodes.
    Bouza E; García de la Torre M; Erice A; Loza E; Diaz-Borrego JM; Buzón L
    Arch Intern Med; 1985 Jun; 145(6):1024-7. PubMed ID: 4004426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of an alternative cefepime dosing strategy in pulmonary and bloodstream infections caused by Enterobacter spp, Citrobacter freundii, and Pseudomonas aeruginosa: a single-center, open-label, prospective, observational study.
    Deal EN; Micek ST; Reichley RM; Ritchie DJ
    Clin Ther; 2009 Feb; 31(2):299-310. PubMed ID: 19302902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bloodstream infections caused by Enterobacter species: predictors of 30-day mortality rate and impact of broad-spectrum cephalosporin resistance on outcome.
    Kang CI; Kim SH; Park WB; Lee KD; Kim HB; Oh MD; Kim EC; Choe KW
    Clin Infect Dis; 2004 Sep; 39(6):812-8. PubMed ID: 15472813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enterobacter bacteremia in the community hospital.
    Haddy RI; Cecil ML; Norris LL; Markert RJ
    J Fam Pract; 1991 Jun; 32(6):601-6. PubMed ID: 2040885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology and Burden of Bloodstream Infections Caused by Extended-Spectrum Beta-Lactamase Producing Enterobacteriaceae in a Pediatric Hospital in Senegal.
    Ndir A; Diop A; Faye PM; Cissé MF; Ndoye B; Astagneau P
    PLoS One; 2016; 11(2):e0143729. PubMed ID: 26867226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kluyvera ascorbata as a Pathogen in Adults and Children: Clinical Features and Antibiotic Susceptibilities in a Single Center Study.
    Lee J; Hwang JH; Jo DS; Lee HS; Hwang JH
    Jpn J Infect Dis; 2019 May; 72(3):142-148. PubMed ID: 30504643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.